$CTSH

Cognizant (NASDAQ: CTSH) director adds RSUs, defers payout

Cognizant (CTSH) director John M. Dineen received RSUs totaling 181.2872 units, credited as dividend equivalent rights. The RSUs are fully vested, with settlement deferred under company guidelines until specific events or dates. No sales or option exercises were reported.

Original reporting
Published Aug 27, 2026, 8:12 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 28, 2026, 4:09 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$CTSH
Neutral
high confidence
Mentioned
$CTSH
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CTSHNeutralLow
01

Why it matters

The filing is a routine insider disclosure with limited trading relevance.

02

Market read

Low impact; primarily a compliance filing.

03

What to watch

Potential future dilution if RSUs are settled after a change of control.

Relevance 4/10Novelty 5/10Timing: today

Background

Cognizant disclosed a director compensation filing detailing RSU awards and deferral conditions.

Company-level read

Ticker impact

$CTSHNeutralHigh confidence
Context

Form 4 filing shows director John M. Dineen received three RSU awards, fully vested but settlement deferred.

Expected impact

minimal effect on stock price

Evidence & confidence

The RSUs are fully vested and settlement is deferred; no cash transaction occurs, so market impact is limited.

Market effects

none

none

none

Counterpoint

The RSU grant could signal confidence in long-term share performance, but market likely ignores it.

Key entities

  • John M. Dineen

    Recipient of the RSU awards.

  • Cognizant Technology Solutions Corp

    Issuer of the RSUs.

Related articles

$CTSHMedAI 8/10

Cognizant's AI Gamble: What Nearshore Must Learn

Cognizant reported Q2 2026 revenue growth of 4.5%, down from Q2 2025, but beat peers and met guidance. Bookings fell 6% YoY. The company raised full-year EPS guidance to $5.70-$5.82, and its stock surged 41.81% in a month. Cognizant cited AI-led demand and partnerships with Google Cloud and Anthropic.

$CTSHMed

Anthropic Is Only Part of the Story. Cognizant Has a Much Bigger AI Plan.

Cognizant (CTSH) trades at a discount versus its historical valuation, with forward GAAP P/E of 8.31x and P/S of 0.97x. In Q2, it reported EPS $1.37 vs $1.38 expected, 4.5% revenue growth, and $459M free cash flow. Management guided Q3 growth 3.8%-5.3% YoY and FY EPS to $5.76 midpoint. Guggenheim cut its price target to $65 but kept a Buy; analysts’ mean target is $60.12.

$CTSHMedAI 8/10

Cognizant Technology Solutions Corporation Q2 2026 Earnings Call Summary

Cognizant Technology Solutions reported 4.1% year-over-year constant-currency revenue growth in Q2 2026, driven by North America and 12% growth in financial services. The company revised full-year revenue guidance to 4% to 5.5% growth and kept adjusted operating margin at 16% to 16.2%. It cited an $81M one-time India benefit, Project LEAP costs, and interest expense after a $1B Astreya-related draw.

$CTSHMed

Cognizant Earnings: Financial Services and North America Drive Resilient Performance

Morningstar’s stock note says Cognizant (CTSH) reported 4% Q2 constant-currency revenue growth, with operating margin steady at 16% and trailing 12-month bookings up 5%. It attributes results to North America and financial services, where growth was 12%. Morningstar keeps a $84 fair value estimate and 16.0%-16.2% operating margin guidance, while trimming full-year revenue growth outlook to 4.0%-5.5%.